Log in using OpenID

Pharmacovigilance Market 2018 Global Market Growth, Size, Share, Trends and Forecasts To 2025

New Market Research Reports Title Pharmacovigilance Market" Has Been Added to Adroit Market Research into reports database.
Adroit Market Research
Global Pharmacovigilance Market
Drivers, Restraints, Potential Growth Opportunities,
Product Size, Application Estimation, Vendor
Competitive Landscape, Trends and Forecast 20182025
Single Use License: US$ 5200
+1 (214) 884-6068
[email protected]
Request Sample
Adroit Market Research
Global Pharmacovigilance Market Size, Share , Forecast Report 2025
• The Global Pharmacovigilance Market Share is being driven by escalated awareness in the public health sector along with
rise in preference for safe medicines. Number of national pharmacovigilance centers is increasing which is playing an
imperative role in aiding the market. Besides that, pharmacovigilance is experiencing various challenges to develop
improved healthcare system. The factor that restrain the market growth is unavailability of unskilled labor and data about
drugs collected via the web. However, rigorous pharmacovigilance activities, if mandated may expand global
Pharmacovigilance market size, encouraging it touch up to USD xx.xx Billion by the end of 2025. The growth rate was
steady in 2018, growing with an optimistic CAGR of x.x% during the forecast period.
• Based on regional segmentation, North America ranks highest in the global pharmacovigilance market because of high
regulatory compliance and incidences of adverse drug reactions for pharmacovigilance. In addition to that, abundant
biotechnology and pharmaceutical companies, is propelling regional market growth. Asia-Pacific considered fastest
growing region of global pharmacovigilance market as there are higher incidences of adverse drug reactions, rising
concern for efficacy and drug safety, and toxicity, and growing number of biotechnology and pharmaceuticals companies.
Moreover, the pharmacovigilance market is rapidly growing because of high growth of generic drugs market in emerging
economies like India and China.
• The global Pharmacovigilance industry is segmented on the basis of methods, clinical trial phase, applications, end-user,
region and service providers. Based on different phases of clinical trial, the market has several categories which include
phase I clinical trial, phase II clinical trial, phase III clinical trial, and phase IV clinical trial. The leading segment is phase IV
clinical trial segment, carrying largest global Pharmacovigilance market share of 75.2% in 2017.
+1 (214) 884-6068
[email protected]
Adroit Market Research
Global Pharmacovigilance Market Size, Share , Forecast Report 2025
• Pharmacovigilance is essential as safety surveillance post drug is sold to patients. It finds and reports ADRs and damaging
effects when drugs are discontinued or restricted in use. Phase IV pharmacovigilance may impact badly on business or
company’s financial performance. Therefore, growing number of pharmaceutical companies and higher number of
medicines favor the market growth. Preclinical trial will have positive growth due to accelerating number of novel drug
developments by biotech and pharma companies across the world. Preclinical trial are essential part of drug development
and drug assessment. Thus, growing demand for targeted therapies owe to higher number of diseases.
• On the basis of pharmacovigilance methods, the global Pharmacovigilance industry is classified as targeted spontaneous
reporting, spontaneous reporting, electronic health record mining, intensified adverse drug reaction reporting and cohort
event monitoring. In terms of service providers, the global pharmacovigilance market is bifurcated into contract
outsourcing pharmacovigilance and in-house pharmacovigilance. Leading segment is contract outsourcing
pharmacovigilance and is anticipated to grow at a higher rate in the next couple of years.
• Some of the main players operating in the global Pharmacovigilance market include Sanofi, Accenture, Cognizant
Technology Solutions, Clinquest Group B.V., Wipro Limited, ICON plc, PAREXEL International Corporation, F. Hoffmann-La
Roche Ltd., Novartis AG, iGATE Corporation, Pfizer Inc., Bristol-Myers Squibb Company and GlaxoSmithKline.
• Browse the complete report on @
+1 (214) 884-6068
[email protected]
Adroit Market Research
Key segments of ‘Global Pharmacovigilance Market’
Based on end-use, the market has been segmented into,
• Pharmaceutical
• Medical Device
• Biotechnological
Based on type of method, the market has been segmented into,
• Targeted Spontaneous Reporting
• Cohort Event Monitoring
• EHR Mining
• Intensified ADR Reporting
• Spontaneous Reporting
Based on region, the market has been segmented into,
• North America
• Latin America
• Europe
• Asia-Pacific
• Middle East and Africa
+1 (214) 884-6068
[email protected]
Adroit Market Research
Global Pharmacovigilance Market Size, Share , Forecast Report 2025
What to expect from the upcoming report on ‘Global Pharmacovigilance Market’:
• - Future prospects and current trends of the global pharmacovigilance market by the end of forecast period (2018-2025)
• - Information regarding technological progressions as well as innovations taking place in developing economies
• - Supportive initiatives by government likely to influence the market dynamics
• - Trends, drivers, opportunities, restraints, challenges and key developments in the market
• - In-depth analysis of different market segmentations including regional segmentations, and product types
• - Deep analysis about the competitive landscape of the market and the initiatives by them to improve this market
Who should buy this report?
• Venture capitalists, Investors, financial institutions, Analysts, Government organizations, regulatory authorities,
policymakers, researchers, strategy managers, and academic institutions looking for insights into the market to determine
future strategies.
• Purchase a single user copy of the global Pharmacovigilance market [email protected]
+1 (214) 884-6068
[email protected]
Adroit Market Research
About Us
Contact Us
Adroit Market Research is an India-based business analytics and consulting company. Our
target audience is a wide range of corporations, manufacturing companies, product/technology
development institutions and industry associations that require understanding of a market’s
size, key trends, participants and future outlook of an industry. We intend to become our
clients’ knowledge partner and provide them with valuable market insights to help create
opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At
our core, we are curious people who love to identify and understand industry patterns, create
an insightful study around our findings and churn out money-making roadmaps. Our analysts
have tracked high growth markets in chemicals & materials, healthcare & pharmaceuticals,
semiconductor & electronics, energy & power, food & retail, consumer goods, technology, and
machinery & equipment sectors across the world to identify new opportunities, potential
customers, prepare go-to-market (GTM) strategies, identify segments for revenue growth for
companies, and many more.
US Headquarters
3131 McKinney Ave Ste 600 Dallas,
TX 75204 ,U.S.A
+1 (214) 884-6068
[email protected]
Phone: +1 (214) 884-6068
Email: [email protected]
Report inappropriate content